Spero Therapeutics
SPRO
NZ$3.85
Share price
-1.29%
Change (1 day)
57.19%
Change (1 year)
Categories
Earnings for Spero Therapeutics (SPRO)
Earnings in 2025 (TTM): -NZ$0.13 Billion
According to Spero Therapeutics's latest financial reports the company's current earnings are NZ$28.3 Million. In 2024 the company made an earning of -NZ$0.13 Billion a decrease over its 2023 earnings that were of NZ$46.6 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Spero Therapeutics from 2017 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -NZ$0.13 Billion | 1.5% |
| 2024 | -NZ$0.13 Billion | -360.42% |
| 2023 | NZ$46.6 M | -163.53% |
| 2022 | -NZ$73.36 Million | -50.14% |
| 2021 | -NZ$0.15 Billion | 11.06% |
| 2020 | -NZ$0.14 Billion | 25.15% |
| 2019 | -NZ$0.11 Billion | 47.68% |
| 2018 | -NZ$71.68 Million | 5.61% |
| 2017 | -NZ$67.87 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Franklin Covey FC | NZ$26.96 M | -122.04% | 🇺🇸 USA |
 IBM IBM | NZ$9.84 B | -8,149.77% | 🇺🇸 USA |
 Thomson Reuters
TRI | NZ$3.37 B | -2,855.35% | 🇨🇦 Canada |